Resistance monitoring of human pathogenic bacteria in Germany, SWOT analysis and examples.
Determination of antibiotic resistance has two main goals in clinical-microbiological diagnosis. One aspect is preservation of antibacterial chemotherapy. Furthermore, trends in resistance development should be monitored and should serve as an early warning-system for occurrence and spread of new and clinically important antibiotic resistances. Plenty of data on antibiotic resistance is gathered on a routine basis in medical-microbiological diagnosis and often it is stored in electronic databases that could be interlinked. The main reason that the available data is not being used for resistance monitoring in Germany is the widely used methodology of the agar diffusion test. It is the cheapest and by far the most inaccurate method of determining resistance. The test results are not always comparable with tests for all substance groups from national standards (also limited international comparability). Trend analysis of the resistance situation in Germany can therefore only be determined through individual studies. These studies are discussed according to a SWOT analysis (SWOT = Strengths, Weaknesses, Opportunities, Threats).
Witte
Wolfgang
W
National Reference Center for Staphylococci, Robert-Koch-Institute, Werningerode, Germany. wittew@rki.de
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001419:Bacteria / Q000187:drug effects*; D001424:Bacterial Infections / Q000175:diagnosis / Q000382:microbiology; D003628:Database Management Systems; D004351:Drug Resistance; D005858:Germany; D006078:Government Programs; D006306:Health Surveys; D006801:Humans; D007256:Information Systems; D007753:Laboratories; D012955:Societies, Medical
D000900:Anti-Bacterial Agents